Metropolitan Life Insurance Company (MetLife)’s Avita Medical RCEL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,414	Closed	-$22.7K	–	1645
2024 Q1	$22.7K	Hold	1,414	–	–	﹤0.01%	1795
2023 Q4	$19.4K	Hold	1,414	–	–	﹤0.01%	1936
2023 Q3	$20.7K	Hold	1,414	–	–	﹤0.01%	1884
2023 Q2	$24.1K	Buy	+1,414	New	+$20.7K	﹤0.01%	1830
2022 Q1	–	Sell	-8,007	Closed	-$95.9K	–	2594
2021 Q4	$95.9K	Hold	8,007	–	–	﹤0.01%	2512
2021 Q3	$142K	Hold	8,007	–	–	﹤0.01%	2316
2021 Q2	$164K	Buy	+8,007	New	+$158K	﹤0.01%	2296

Other funds holding RCEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s RCEL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 1,414 shares — an estimated $22.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RCEL in Q2 2021 and held it in 7 quarters. The position peaked at $164K in Q2 2021. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,414 Avita Medical shares in Q2 2024, an estimated $22.7K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Avita Medical in Q2 2021 and held it in 7 quarters.
Metropolitan Life Insurance Company (MetLife)'s Avita Medical position peaked at $164K in Q2 2021.
68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.